Starting Monday July 29 at 11 AM, the CITI Program website, hosting the human research ethics training modules, will be unavailable for two to three days (perhaps until Friday August 2) to complete a major software upgrade
Repeat presentation by OHRE Director, Dan Nelson: “Evolving Oversight for Multisite Research: Results of a Randomized, Controlled Trial of Central vs. Local IRB Review.” June 13, 2013, 3:00-4:00 pm, Bondurant Hall G100. We recently conducted a novel pilot project to … Read more
Unsubmitted online application drafts inactive for the past 9 months will be deleted May 23. If you DO NOT wish your draft to be deleted, make any edit and click the save button. Only unsubmitted drafts will be deleted, not … Read more
When completing your IRB application, you may now alternatively satisfy a full-consent form requirement by indicating either that you have requested a waiver of consent entirely (at D.3), or a waiver of written consent (at D.2). To do so, at … Read more
The questions in the IRB application (section A.4.A; #s 4 and 5) relating to Investigational New Drug (IND) applications have been expanded and clarified. As a reminder, the IND Exemption Checklist is available as a paper form at our website, … Read more
